Lot-to-Lot Variability in Biologics and Biosimilars: What Patients and Providers Need to Know
Lot-to-lot variability is normal in biologics and biosimilars due to their complex, cell-based production. Unlike generics, biosimilars aren't identical copies-but they're rigorously proven to be safe and effective. Here's what patients and providers need to know.
Continue Reading